Clinical Trials on Obesity Type I and II in Argentina

Total 660 results

GI Windows, Inc.

Active, not recruiting

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

Obesity | Type 2 Diabetes

Argentina
Instituto de Desarrollo e Investigaciones Pediátricas...

Recruiting

Maternal Characteristics Associated With Child Growth and Adiposity

Obesity | Obesity, Infant

Argentina
Clínica Bazterrica

Withdrawn

Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors

Obesity

Argentina
Protein Supplies SL

Withdrawn

Cost-effectiveness Study of a Multidisciplinary Weight Loss Method to Improve the Health Condition of Obese Patients (PRONOCOST)

Obesity | Obese

Argentina
Instituto de Desarrollo e Investigaciones Pediátricas...

Completed

Pre- and Post-prandial Levels of Appetite Regulatory Hormones in Adults

Obesity | Appetitive Behavior

Argentina
National Council of Scientific and Technical Research...
Illumina, Inc.; Facultad de Ingeniería - Universidad Austral; Instituto de Inmunología... and other collaborators

Recruiting

Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention (MicrobiAr)

Obesity | Diabetes Mellitus, Type 2 | PreDiabetes

Argentina
ValenTx, Inc.

Unknown

The ePass Clinical Trial for the Treatment of Obese Subjects (ePass)

Obesity

Argentina, Mexico
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Sanofi

Active, not recruiting

Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 (ELIKIDS)

Gaucher's Disease Type III | Gaucher's Disease Type I

Canada, Argentina, France, Italy, Japan, Russian Federation, Spain, Sweden, Turkey, United Kingdom
Austral University, Argentina

Recruiting

Cardiometabolic Risk Factors Registry (CARFARE)

Cardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk Factor

Argentina
PINER Pastor Manfredi Winery
University of Buenos Aires

Completed

Biological Effects in Consumers of Resveratrol-enriched Wine

Obesity | Sarcopenia | Aging | Healthy Aging

Argentina
Ministry of Public Health, Argentina
Aix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...

Unknown

Effect of Linagliptin on TRL Metabolism

Type 2 Diabetes

Argentina
Sanofi

Terminated

Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2) (Malbec)

Type 2 Diabetes

Argentina
School of Medicine. National University of Cuyo

Recruiting

Argentine Registry of Lp(a) (GAELpa)

Cardiovascular Diseases | Hypertension | Hypercholesterolemia | Diabete Type 2 | Lp(A)

Argentina
Diatranz Otsuka Limited

Completed

Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Argentina
Sanofi

Completed

A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients

Obesity

France, Spain, Argentina, Finland, Australia
Hospital Italiano de Buenos Aires

Completed

Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)

Postoperative Complications

Argentina
Hospital Italiano de Buenos Aires
Universidad Nacional de La Plata; Instituto Tecnológico de Buenos Aires; Fundación...

Completed

Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting

Type 1 Diabetes | Autoimmune Diabetes

Argentina
Hospital General Puyo

Unknown

Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group

Type1diabetes | Childhood ALL

Argentina
Boston Scientific Corporation

Completed

The ACE Follow-up Study

Obesity

Netherlands, Argentina, Canada, Israel
Hoffmann-La Roche

Completed

A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

Urothelial Carcinoma

Argentina
Centro de Endocrinologia Experimental y Aplicada
National Council of Scientific and Technical Research, Argentina

Completed

Educative Intervention to Improve Type 2 Diabetes Mellitus Control in Corrientes (PRODIACOR)

Type 2 Diabetes

Argentina
Grupo Argentino de Tratamiento de la Leucemia Aguda

Unknown

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia

Leukemia

Argentina
Novo Nordisk A/S

Completed

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Argentina
Hospital Italiano de Buenos Aires

Completed

Effectiveness of a High-risk Diabetic Patients Program

Diabetes Mellitus, Type 2

Argentina
Living Cell Technologies

Completed

Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Argentina
Sunovion

Completed

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex (PERSIST)

Bipolar I Disorder

United States, Croatia, Hungary, Poland, Serbia, Argentina, Japan, France, Slovakia, Australia, Russian Federation, Bulgaria, Chile, Czech Republic
Hoffmann-La Roche

Completed

Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina

Chronic Lymphocytic Leukemia

Argentina
Sunovion

Completed

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (PERSISTExt)

Bipolar I Disorder

United States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects

Diabetes Mellitus, Type 2

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Racotumomab in Patients With High-risk Neuroblastoma

Neuroblastoma

Argentina
Hospital JP Garrahan
Hospital Pereyra Rosell, Montevideo, Uruguay

Recruiting

Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation. (LHGALOP2017)

Pediatric Hodgkin's Disease

Argentina
Mela Osorio Maria Jose
Janssen-Cilag Ltd.

Completed

A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia

CLL

Argentina
Laboratorio Pablo Cassará S.R.L.
National Council of Scientific and Technical Research, Argentina; Fundacion... and other collaborators

Unknown

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Cutaneous Melanoma

Argentina
José Mordoh, M.D., Ph.D.

Completed

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Melanoma

Argentina
Mauro Fisberg
Pontificia Universidad Catolica de Chile; Pontificia Universidad Javeriana; Universidad... and other collaborators

Completed

Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud

Physical Activity | Dietary Habits | Overweight and Obesity

Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Peru, Venezuela
Genzyme, a Sanofi Company

Completed

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease (COMET)

Glycogen Storage Disease Type II;Pompe's Disease

Czechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more
Instituto Nacional del Cáncer, Argentina
International Agency for Research on Cancer; National Council of Scientific... and other collaborators

Completed

Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake (EMA)

Cervical Intraepithelial Neoplasia

Argentina
Sanofi

Terminated

Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus (SAMS)

Sleep Initiation and Maintenance Disorders

United States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
Takeda

Completed

A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma Kinase

Argentina
Hospital JP Garrahan

Completed

Phase I Trial of Periocular Topotecan in Retinoblastoma

Retinoblastoma

Argentina
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Argentina
Genzyme, a Sanofi Company

Recruiting

Mucopolysaccharidosis I (MPS I) Registry

Mucopolysaccharidosis I (MPS I)

Croatia, United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, France, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, Slovaki... and more
Hospital JP Garrahan
Hospital San Juan de Dios, Santiago

Active, not recruiting

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma (RbGALOP2)

Unilateral Retinoblastoma

Argentina
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

Diabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin Dependent

United States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
Denali Therapeutics Inc.

Recruiting

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) (COMPASS)

Mucopolysaccharidosis II

United States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Colombia, Brazil
Grupo Argentino de Tratamiento de la Leucemia Aguda

Recruiting

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

Acute Lymphoblastic Leukemia, Adult

Argentina
University Hospital, Geneva

Unknown

Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Pancreatic Neoplasms | Cholangiocarcinoma | Pancreatitis

Argentina
Zimmer Biomet

Completed

A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.

Tumor | Neuroma | Mandibular Fractures | Treacher Collins Syndrome | Facial Fracture | Fibrous Dysplasia | Hemifacial Microsomia | Miller Syndrome | Osteoma of Mandibular Condyle | Cleft Face | Nager Syndrome

Argentina
Sanofi
Regeneron Pharmaceuticals

Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Hypercholesterolaemia

Czechia, France, Denmark, Netherlands, Austria, Mexico, Spain, United States, Argentina, Brazil, Bulgaria, Canada, Finland, Hungary, Italy, Lebanon, Norway, Poland, Russian Federation, Slovenia, South Africa, Sweden, Taiwan, Turkey

Clinical Trials on Obesity Type I and II in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations